ContraFect Corporation
CFRXQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.09 | 0.20 | 0.06 |
| FCF Yield | -1,149.74% | -42.52% | -28.87% | -53.36% |
| EV / EBITDA | 0.03 | -4.14 | -3.68 | -2.47 |
| Quality | ||||
| ROIC | -4,817.02% | -85.56% | -73.88% | -108.93% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.71 | 2.03 | 1.18 | 2.14 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -11.94% | -23.92% | -20.91% | -4.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.09 | 0.66 | 0.42 | 1.61 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -32,402.05 | -5,891.79 | -3,917.94 | -5,658.16 |